Differential effects of the calcium channel blocker nifedipine on renal microcirculation: A comparative study using hydronephrotic rats

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 6, 2000, Pages 367-375

  Kimura, Kenjiro ^a   Suzuki, Naoe ^a   Kamijo, Atuko ^a   Mise, Naobumi ^a   Oba, Shigeyoshi ^a   Miyashita, Kazuhisa ^a   Hirata, Yasunobu ^a   Goto, Atsuo ^a   Fujita, Tosiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensinconverting enzyme inhibitor; Calcium channel antagonist; Hydronephrotic kidney; Imidapril; Nifedipine; Rats

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; IMIDAPRIL; NIFEDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIAGNOSTIC ACCURACY; GLOMERULUS BASEMENT MEMBRANE; HYDRONEPHROSIS; IMAGE QUALITY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033949353     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)80006-5     Document Type: Article

References (15)

1. 1. Dworkin LD, Feiner HD, Parker M, et al. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR. Kidney Int. 1991;39:1112-1117.
2. 2. Brunner FP, Thiel G, Hermle M, et al. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int. 1989;36:969-977.
3. 3. Anderson S, Rennke HG, Brenner BM, et al. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int. 1992;41:891-897.
4. 4. Murray KM. Calcium-channel blockers for treatment of diabetic nephropathy. Clin Pharm. 1991;10:862-865.
5. 5. Zucchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int. 1992;42:452-458.
6. 6. Buhrle CP, Hackenthal E, Helmchen U, et al. The hydronephrotic kidney of the mouse as a tool for intravital microscopy and in vitro electrophysiological studies of renin-containing cells. Lab Invest. 1986;54:462-472.
7. 7. Kimura K, Suzuki N, Ohba S, et al. Effects of amlodipine, a calcium channel blocker, on rat renal arterioles. Curr Ther Res Clin Exp. 1997;58:375-380.
8. 8. Kimura K, Suzuki N, Mise N, et al. Vasodilating effects of the beta-adrenoceptor blocker, nipradilol on the renal microcirculation: A comparative study with propranolol. Curr Ther Res Clin Exp. 1998;59:179-186.
9. 9. Kimura K, Tojo A, Hirata Y, et al. Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles. Blood Press Suppl. 1994;5:71-74.
10. 10. Wayne R. NIH image. Available at: www.zippy.nimh.nih.gov. Accessed October 1996.
11. 11. Kimura K, Hirata Y, Nanba S, et al. Effects of atrial natriuretic peptide on renal arterioles: Morphometric analysis using microvascular casts. Am J Physiol. 1990;259:F936-F944.
12. 12. Fleming JT, Garthoff B, Mayer D, et al. Comparison of the effects of antihypertensive drugs on pre-and postglomerular vessels of the hydronephrotic kidney. J Cardiovasc Pharmacol. 1987;10(Suppl):S14-S53.
13. 13. Fleming JT, Parekh N, Steinhausen M. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol. 1987;253:F1157-F1163.
14. 14. Anderson S, Meyer TW, Rennke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612-619.
15. 15. Meyer TW, Anderson S, Rennke HG, et al. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency. Am J Med. 1985;79:31-36.